Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function.
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.
Negative work events and accommodations in employed multiple sclerosis patients.
Internal jugular veins out flow in patients with multiple sclerosis:a catheter venography study.
Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain.
Clinical applications of diffusion imaging in the spine.
B-mode transorbital ultrasononography for the diagnosis of acute optic neuritis. A systematic review.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Do Patients With Multiple Sclerosis Show Different Daily Physical Activity Patterns From Healthy Individuals?
Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.
Podoplanin negatively regulates CD4+ effector T cell responses.
Support our campaign for better treatment for people with MS.
The new era of multiple sclerosis therapy.
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals.
Comparing adherence rates to disease modifying therapies for multiple sclerosis in commercial enrollees and Part D beneficiaries.
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.
Case centered analysis of Optic Neuritis following vaccines.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
The potential of epigenetic therapies in neurodegenerative diseases.
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
Pages
« first
‹ previous
…
576
577
578
579
580
581
582
583
584
…
next ›
last »